Uptake of Gd-EOB-DTPA in Bone and Splenic Metastases from Hepatocellular Carcinoma: A Case Study
Journal: Austin Journal of Gastroenterology (Vol.4, No. 1)Publication Date: 2017-02-09
Authors : Zheng L Zhao Y Chen W; Tian R;
Page : 1-3
Keywords : Gd-EOB-DTPA; HCC; Bone metastases; Splenic metastases;
Abstract
We present the case of bone and splenic metastases from hepatocellular carcinoma (HCC), which showed uptake of gadolinium-ethoxybenzyldiethylenetriaminepentaacetic acid (Gd-EOB-DTPA) on magnetic resonance imaging (MRI). To the best of our knowledge, this is the first case of bone and splenic metastases from HCC that demonstrated uptake of Gd-EOB-DTPA in the hepatobiliary phase.
Other Latest Articles
- Metastatic Kaposi’s Sarcoma Causing Gastrointestinal Bleeding: Report of an Unusual Case
- Increase Writing Performance using a Shaping Procedure with a Patient with Sequelae caused by Cardiovascular Accident
- Conventional and Targeted Therapy in Metastatic Colorectal Cancer
- Facilitators and barriers to health care access among the elderly in Tanzania: A health system perspective from managers and service providers
- Hematochezia in a Liver Transplant Recipient with Incisional Hernia Repair
Last modified: 2017-12-08 18:38:21